Income Taxes (Details Narrative) (10-K) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
Dec. 22, 2017 |
Sep. 30, 2019 |
Dec. 31, 2018 |
Sep. 30, 2018 |
Dec. 31, 2017 |
Sep. 30, 2019 |
Sep. 30, 2018 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
| Effective tax statutory rate | 35.00% | 21.00% | 21.00% | 21.00% | 34.00% | 21.00% | 21.00% | 34.00% | |
| Provision for income taxes | |||||||||
| Income tax offset percentage | 80.00% | ||||||||
| Reduced tax rate | 21.00% | ||||||||
| Deferred tax asset | 3,800,000 | ||||||||
| Refundable tax credit | $ 17,253 | ||||||||
| Hawaii Income Tax Purposes [Member] | |||||||||
| Operating loss carry forwards | $ 29,286,880 | $ 29,286,880 | |||||||
| Federal [Member] | |||||||||
| Operating loss carry forwards | $ 36,950,157 | $ 36,950,157 | |||||||
| X | ||||||||||
- Definition Income tax offset percentage. No definition available.
|
| X | ||||||||||
- Definition Refundable tax credit. No definition available.
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deductions. Including, but not limited to, extraterritorial income exclusion deduction, qualified production activity deduction, dividend deduction, deduction for dividend paid to employee stock ownership plan, Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|